These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 37450960)
41. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. Jurewitsch B; Lee T; Park J; Jeejeebhoy K JPEN J Parenter Enteral Nutr; 1998; 22(4):242-4. PubMed ID: 9661127 [TBL] [Abstract][Full Text] [Related]
42. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070 [TBL] [Abstract][Full Text] [Related]
43. A new central venous catheter cap: decreased microbial growth and risk for catheter-related bloodstream infection. Buchman AL; Spapperi J; Leopold P J Vasc Access; 2009; 10(1):11-21. PubMed ID: 19340794 [TBL] [Abstract][Full Text] [Related]
44. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Betjes MG; van Agteren M Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498 [TBL] [Abstract][Full Text] [Related]
45. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study. Al-Ali F; Hamdy AF; Hamad A; Elsayed M; Zafar Iqbal Z; Elsayed A; Ibrahim R; Tolba H; Buanan H; Fawzy A Nephrol Dial Transplant; 2018 Apr; 33(4):619-626. PubMed ID: 29106676 [TBL] [Abstract][Full Text] [Related]
46. Comparison of catheter-related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil-based intravenous fat emulsion versus a mixed oil fat emulsion. Alvira-Arill GR; Herrera OR; Tsang CCS; Wang J; Peters BM; Stultz JS Pharmacotherapy; 2022 Dec; 42(12):898-904. PubMed ID: 36349792 [TBL] [Abstract][Full Text] [Related]
48. Antimicrobial Efficacy and Safety of a Novel Gas Plasma-Activated Catheter Lock Solution. Bhatt S; Mehta P; Chen C; Daines DA; Mermel LA; Chen HL; Kong MG Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844050 [TBL] [Abstract][Full Text] [Related]
49. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin. Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287 [TBL] [Abstract][Full Text] [Related]
50. [Causative agents of intravenous catheter-related infections and their antibiotic susceptibilities]. Aktaş E; Sarı EN; Seremet Keskin A; Pişkin N; Külah C; Cömert F Mikrobiyol Bul; 2011 Jan; 45(1):86-92. PubMed ID: 21341163 [TBL] [Abstract][Full Text] [Related]
51. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year. Ludden C; Cormican M; Vellinga A; Johnson JR; Austin B; Morris D BMC Infect Dis; 2015 Apr; 15():168. PubMed ID: 25887288 [TBL] [Abstract][Full Text] [Related]
52. Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. Bradshaw JH; Puntis JW J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):179-86. PubMed ID: 18664870 [TBL] [Abstract][Full Text] [Related]
53. In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections. Cobrado L; Silva-Dias A; Azevedo MM; Pina-Vaz C; Rodrigues AG J Antimicrob Chemother; 2013 Jan; 68(1):126-30. PubMed ID: 22991425 [TBL] [Abstract][Full Text] [Related]